Literature DB >> 16651873

D-dimer is not a long-term prognostic marker following acute cerebral ischemia.

Alessandro Squizzato1, Walter Ageno, Sergio Finazzi, Valentina Mera, Erica Romualdi, Anna Bossi, Achille Venco.   

Abstract

Recent evidence indicates a possible role of D-dimer in the early diagnosis of ischemic stroke subtypes. Whether D-dimer can also predict the long-term outcome following ischemic stroke is controversial. To define the prognostic role of D-dimer, patients hospitalized after an acute ischemic cerebrovascular event underwent D-dimer measurement (Liatest D-D; normal level < 0.50 microg/ml) on admission and were followed up for recurrent cerebrovascular events, occurrence of other cardiovascular events, and mortality. We enrolled 96 patients (mean age 74.9 years, 42 men). Mean follow-up was 61.5 months; 47 (48.5%) patients died, 23 (48.9%) because of a vascular event. There was no difference in mean D-dimer levels between dead patients and survivors (1.68 and 1.63 microg/ml, P = NS), but the mortality risk was higher with D-dimer of at least 0.50 microg/ml (odds ratio, 5.32; 95% confidence interval, 1.79-15.84). After adjustment for age and stroke subtype, the odds ratio was not significant. Mean D-dimer was similar between patients with and without a new vascular event (1.43 and 1.68 microg/ml, P = NS), and D-dimer of at least 0.50 microg/ml was not predictive of an increased risk of subsequent events. D-dimer levels measured in the acute phase after an acute cerebrovascular event probably do not predict the long-term clinical outcome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16651873     DOI: 10.1097/01.mbc.0000224850.57872.d0

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  8 in total

1.  The relationship between plasma D-dimer levels and outcome of Chinese acute ischemic stroke patients in different stroke subtypes.

Authors:  Wei Yuan; Zheng-Hong Shi
Journal:  J Neural Transm (Vienna)       Date:  2013-11-08       Impact factor: 3.575

2.  Impact of D-dimer levels for short-term or long-term outcomes in cryptogenic stroke patients.

Authors:  Tomohisa Nezu; Takaya Kitano; Satoshi Kubo; Junichi Uemura; Shinji Yamashita; Takeshi Iwanaga; Takeshi Inoue; Naohisa Hosomi; Hirofumi Maruyama; Masayasu Matsumoto; Kazumi Kimura; Yoshiki Yagita
Journal:  J Neurol       Date:  2018-01-25       Impact factor: 4.849

3.  The follow-up of patients of sixty-five years of age and younger with acute ischemic stroke and transient ischemic attacks, and elevated D-dimer levels in plasma.

Authors:  Magnus Vrethem; Tomas Lindahl
Journal:  Neurol Int       Date:  2009-11-16

4.  Predictors of poor outcome in patients with acute cerebral infarction.

Authors:  Nobuhiro Dougu; Shutaro Takashima; Etsuko Sasahara; Yoshiharu Taguchi; Shigeo Toyoda; Tadakazu Hirai; Takashi Nozawa; Kortaro Tanaka; Hiroshi Inoue
Journal:  J Clin Neurol       Date:  2011-12-29       Impact factor: 3.077

Review 5.  Point-of-Care-Testing in Acute Stroke Management: An Unmet Need Ripe for Technological Harvest.

Authors:  Dorin Harpaz; Evgeni Eltzov; Raymond C S Seet; Robert S Marks; Alfred I Y Tok
Journal:  Biosensors (Basel)       Date:  2017-08-03

6.  FM Combined With NIHSS Score Contributes to Early AIS Diagnosis and Differential Diagnosis of Cardiogenic and Non-Cardiogenic AIS.

Authors:  Dan Wu; Yong'e Liu
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

Review 7.  D-Dimer elevation and adverse outcomes.

Authors:  Rim Halaby; Christopher J Popma; Ander Cohen; Gerald Chi; Marcelo Rodrigues Zacarkim; Gonzalo Romero; Samuel Z Goldhaber; Russell Hull; Adrian Hernandez; Robert Mentz; Robert Harrington; Gregory Lip; Frank Peacock; James Welker; Ignacio Martin-Loeches; Yazan Daaboul; Serge Korjian; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2015-01       Impact factor: 2.300

8.  Prognostic role of early D-dimer level in patients with acute ischemic stroke.

Authors:  Jing Zhang; Lin Liu; Jie Tao; Yanlin Song; Yimeng Fan; Maling Gou; Jianguo Xu
Journal:  PLoS One       Date:  2019-02-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.